BPG is committed to discovery and dissemination of knowledge
This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article
Bai JA, Xu GF, Yan LJ, Zeng WW, Ji QQ, Wu JD, Tang QY. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis. World J Gastroenterol 2015; 21(20): 6180-6193 [PMID: 26034353 DOI: 10.3748/wjg.v21.i20.6180]

Corresponding Author of This Article
Qi-Yun Tang, MD, PhD, Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing 210029, China. tqy831@163.com

Checklist of Responsibilities for the Scientific Editor of This Article

Publishing Process of This Article

Research Domain of This Article
Gastroenterology & Hepatology

Article-Type of This Article
Basic Study

Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7692)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2015 (publication date) through Dec 1, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Total Visits of This Article
2019 | Number of total visits
Rank | Countries/Territories | Count | Percent |
1 | 61 | 100% |